The patient was seen in the Clinic on [**2189-12-14**], initially and treated with Biaxin for a pneumonia.
The patient did not tolerate a trial of BiPAP in the Emergency Department.
Hepatitis C, status post 48 weeks of Interferon treatment.
SOCIAL HISTORY:  The patient reports a history of intravenous drug use and is currently on Methadone maintenance.
The patient has not used intravenous drugs for greater than ten years.
Methadone 20 mg p.o.
Klonopin one tab p.o.
Combivir one tab p.o.
Crixivan one tab p.o.
Biaxin 500 mg p.o.
Urine toxicology was positive for benzodiazepines, Methadone and opiates.
Pneumonia - The patient was initially on Levofloxacin and Ceftriaxone for the purpose of community acquired pneumonia.
On hospital day #2, the patient was also started on Vancomycin given a gram stain sputum positive for Methicillin resistant Staphylococcus aureus.
Subsequently, Levofloxacin and Ceftriaxone were discontinued.
At the time of discharge, the patient remains on day #9 of #14 of Vancomycin therapy.
On hospital day #2, the patient was transferred to the Floor where he continued to require oxygen supplementation via nasal cannula.
The patient was given nebulizer treatments and pulmonary toilet with expiration of thick secretions and improvement in saturations to 94% on a 70% mask.
He was placed on 100 percent nonrebreather and a blood gas at this time revealed a pH of 7.24/CO2 95%/O2 139.
The patient was given a 0.4 mg dose of Narcan and the patient was noted to be more arousable.
After the fourth total dose of the morning, the patient continued to have a stable respiratory status with the last gas revealing 7.44/57/58 on six liters of nasal cannula.
Upon discharge, the patient continues to require six liters of nasal cannula in order to maintaine oxygen saturations greater than 92%.
Human immunodeficiency:  Initially upon admission the patient's anti-retroviral of medications were held secondary to poor p.o.
HAART therapy was resumed on hospital day #2 as the patient tolerated p.o.'s.
Current regimen was continued throughout the remainder of the hospital stay.
The impression was that this may be consistent with HIV cholangiopathy and recommended further evaluation as needed.
Heparin induced thrombocytopenia antibody was sent and remains pending at this time.
All Heparin flushes and subcutaneous Heparin were discontinued at this time.
The patient should be continued on lower dose of Methadone maintenance therapy.
If patient shows signs of acute narcotic withdrawal, the patient may be given an additional 10 mg dose of Methadone as needed with careful monitoring of his respiratory status.
The patient received a PICC line for administration of antibiotics.
Vancomycin 1 gram intravenous q 12 hours, last day is [**2189-12-30**].
Adenovir 800 mg p.o.
Methadone 50 mg p.o.
